Cognitive biases can affect moral intuitions about cognitive enhancement

Frontiers in Systems Neuroscience

Volumn 8, Issue OCT, 2014, Pages

  Caviola, Lucius ^a   Mannino, Adriano ^b   Savulescu, Julian ^c   Faulmüller, Nadira ^a,c,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

Attitudes; Brain function augmentation; Cognitive bias; Cognitive enhancement; De biasing; Moral intuitions; Rationality

Indexed keywords

METHYLPHENIDATE; MODAFINIL;

ARTICLE; AVERSION; COGNITIVE BIAS; ENDOWMENT EFFECT; ETHICAL DECISION MAKING; HUMAN; INTUITION; NATURE BIAS; OMISSION BIAS; OPTIMISTIC BIAS; SOCIAL ATTITUDE; WEIGHT REDUCTION;

EID: 84907964458     PISSN: 16625137     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnsys.2014.00195     Document Type: Article

References (57)

1. Audi, R. (2001). The Architecture of Reason: The Structure and Substance of Rationality. New York, NY: Oxford University Press.
2. Baron, J. (2005). Thinking and Deciding. Cambridge, MA: Cambridge University Press.
3. Baron, J., and Greene, J. (1996). Determinants of insensitivity to quantity in valuation of public goods: contribution, warm glow, budget constraints, availability and prominence. J. Exp. Psychol. Appl. 2, 107-125. doi: 10.1037/1076-898x.2.2.107
4. Bergström, L. S., and Lynöe, N. (2008). Enhancing concentration, mood and memory in healthy individuals: an empirical study of attitudes among general practitioners and the general population. Scand. J. Public Health 36, 532-537. doi: 10.1177/1403494807087558
5. Bostrom, N. (2008). "Three ways to advance science," in Nature Podcast. Available online at:http://www.nickbostrom.com/views/science.pdf. Accessed on January 31, 2008.
6. Bostrom, N., and Ord, T. (2006). The reversal test: eliminating status quo bias in applied ethics. Ethics 116, 656-679. doi: 10.1086/505233
7. Bostrom, N., and Sandberg, A. (2009). Cognitive enhancement: methods, ethics, regulatory challenges. Sci. Eng. Ethics 15, 311-341. doi: 10.1007/s11948-009-9142-5
8. Chapin, J., and Coleman, G. (2009). Optimistic bias: what you think, what you know, or whom you know?. N. Am. J. Psychol. 11, 121-132. Available online at: http://www.questia.com/library/journal/1G1-195427665/optimistic-bias-what-you-think-what-you-know-or
9. Cosmides, L., and Tooby, J. (1992). "Cognitive adaptations for social exchange," in The Adapted Mind: Evolutionary Psychology and the Generation of Culture, eds J. Barkow, L. Cosmides and J. Tooby (New York, NY: Oxford University Press), 163-228.
10. Cowan, B. W. (2005). The Social Life of Coffee: The Emergence of the British Coffee House. New Haven, CT: Yale University Press.
11. Dawes, R. M. (1998). "Behavioral decision making and judgment," in The Handbook of Social Psychology (Vol. 1), eds D. T. Gilbert, S. T. Fiske and G. Lindzey 4th Edn. (Boston, MA: McGraw-Hill), 497-548.
12. Desvousges, W. H., Johnson, F. R., Dunford, R. W., Boyle, K. J., Hudson, S. P., Wilson, K. N., et al. (2010). Measuring Nonuse Damages Using Contingent Valuation: An Experimental Evaluation of Accuracy. 2nd Edn. Research Triangle Park, NC: RTI Press.
13. Dietz, P., Striegel, H., Franke, A. G., Lieb, K., Simon, P., and Ulrich, R. (2013). Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students. Pharmacotherapy 33, 44-50. doi: 10.1002/phar.1166
14. Elliott, C. (2004). Better Than Well: American Medicine Meets the American Dream. New York: W. W. Norton and Company.
15. Faulmüller, N., Maslen, H., and Santoni de Sio, F. (2013). The indirect psychological costs of cognitive enhancement. Am. J. Bioeth. 13, 45-47. doi: 10.1080/15265161.2013.794880
16. Festinger, L. (1957). A Theory of Cognitive Dissonance. Stanford, CA: Stanford University Press.
17. Fitz, N. S., Nadler, R., Manogaran, P., Chong, E. W. J., and Reiner, P. B. (2013). Public attitudes toward cognitive enhancement. Neuroethics 7, 173-188. doi: 10.1007/s12152-013-9190-z
18. Foley, R. (1987). The Theory of Epistemic Rationality. Cambridge, MA: Harvard University Press.
19. Forlini, C., and Racine, E. (2009). Autonomy and coercion in academic "Cognitive Enhancement" using methylphenidate: perspectives of key stakeholders. Neuroethics 2, 163-177. doi: 10.1007/s12152-009-9043-y
20. Forlini, C., and Racine, E. (2012). Stakeholder perspectives and reactions to "academic" cognitive enhancement: unsuspected meaning of ambivalence and analogies. Public Underst. Sci. 21, 606-625. doi: 10.1177/0963662510385062
21. Franke, A. G., Bagusat, C., Dietz, P., Hoffmann, I., Simon, P., Ulrich, R., et al. (2013). Use of illicit and prescription drugs for cognitive or mood enhancement among surgeons. BMC Med. 11:102. doi: 10.1186/1741-7015-11-102
22. Fukuyama, F. (2004). Transhumanism. Foreign Policy 144, 42-43. doi: 10.2307/4152980
23. Gangarosa, E. J., Galazka, A. M., Wolfe, C. R., Phillips, L. M., Gangarosa, R. E., Miller, E., et al. (1998). Impact of anti-vaccine movements on pertussis control: the untold story. Lancet 351, 356-361. doi: 10.1016/s0140-6736(97)04334-1
24. Habermas, J. (2003). The Future of Human Nature. Cambridge, UK: Polity Press.
25. Harris, J. (2010). Enhancing Evolution: The Ethical Case for Making Better People. Princeton: Princeton University Press.
26. Healey, P., and Rayner, S. (2008). Unnatural Selection: The Challenges of Engineering Tomorrow's People.London: Earthscan.
27. Herman-Stahl, M. A., Krebs, C. P., Kroutil, L. A., and Heller, D. C. (2007). Risk and protective factors for methamphetamine use and nonmedical use of prescription stimulants among young adults aged 18 to 25. Addict. Behav. 32, 1003-1015. doi: 10.1016/j.addbeh.2006.07.010
28. Husain, M., and Mehta, M. A. (2011). Cognitive enhancement by drugs in health and disease. Trends Cogn. Sci. 15, 28-36. doi: 10.1016/j.tics.2010.11.002
29. Jay, T. B. (1981). Computerphobia: what to do about it. Educ. Technol. 21, 47-48.
30. Kahan, D. M., Peters, E., Dawson, E. C., and Slovic, P. (2013). "Motivated numeracy and enlightened self-government," in Yale Law School Public Law Working Paper 307 (New Haven, CT).
31. Kahneman, D. (2000). "Evaluation by moments: past and future," in Choices, Values and Frames, eds D. Kahneman and A. Tversky (New York, NY: Cambridge University Press and Russell Sage Foundation), 693-708.
32. Kahneman, D., and Knetsch, J. L. (1992). Valuing public goods: the purchase of moral satisfaction. J. Environ. Econ. Manage. 22, 57-70. doi: 10.1016/0095-0696(92)90019-s
33. Kahneman, D., Knetsch, J. L., and Thaler, R. H. (1991). Anomalies: the endowment effect, loss aversion and status-quo bias. J. Econ. Perspect. 5, 193-206. doi: 10.1257/jep.5.1.193
34. Kahneman, D., and Tversky, A. (1984). Choices, values and frames. Am. Psychol. 39, 341-350. doi: 10.1037//0003-066x.39.4.341
35. King, S., Griffin, S., Hodges, Z., Weatherly, H., Asseburg, C., Richardson, G., et al. (2006). A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. Health Technol. Assess.10, iii-iv, xiii-146. doi: 10.3310/hta10230
36. Kunda, Z. (1990). The case for motivated reasoning. Psychol. Bull. 108, 480-498. doi: 10.1037//0033-2909.108.3.480
37. Larrick, R. P. (2004). "Debiasing," in Blackwell Handbook of Judgment and Decision Making, eds J. Koehler and N. Harvey (Malden, MA: Blackwell), 316-337.
38. Mahdawi, A. (2012). "Speed and the city: meet the Adderall-addled adults of New York," in The Guardian. Available online at: http://www.theguardian.com/commentisfree/2012/oct/12/adderall-new-york-capitalism. Accessed on October 12, 2012.
39. Maslen, H., Faulmüller, N., and Savulescu, J. (2014). Pharmacological cognitive enhancement-how future neuroscientific research could advance ethical debate. Front. Syst. Neurosci. 8:107. doi: 10.3389/fnsys.2014.00107
40. Maslen, H., Santoni de Sio, F., and Faulmüller, N. (in press). "With cognitive enhancement comes great responsibility?," in Responsible Innovation (Vol. 2), eds B. J. Koops (Dordrecht: Springer).
41. Partridge, B., Bell, S., Lucke, J., and Hall, W. (2013). Australian university students' attitudes towards the use of prescription stimulants as cognitive enhancers: perceived patterns of use, efficacy and safety. Drug Alcohol Rev.32, 295-302. doi: 10.1111/dar.12005
42. Repantis, D., Schlattmann, P., Laisney, O., and Heuser, I. (2010). Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Pharmacol. Res. 62, 187-206. doi: 10.1016/j.phrs.2010.04.002
43. Ritov, I., and Baron, J. (1990). Reluctance to vaccinate: omission bias and ambiguity. J. Behav. Decis. Mak. 3, 263-277. doi: 10.1002/bdm.3960030404
44. Samuelson, W., and Zeckhauser, R. (1988). Status quo bias in decision making. J. Risk Uncertain. 1, 7-59. doi: 10.1007/bf00055564
45. Sandel, M. J. (2004). The case against perfection: what's wrong with designer children, bionic athletes and genetic engineering. Atl. Mon. 292, 50-54, 56-60, 62.
46. Savulescu, J. (2006). "Justice, fairness and enhancement," in Progress in Convergence: Technologies for Human Wellbeing, eds W. S. Bainbridge and M. C. Roco (Danvers, MA: Wiley-Blackwell), 321-338.
47. Savulescu, J. (2007). "Genetic interventions and the ethics of enhancement of human beings," in The Oxford Handbook of Bioethics, ed B. Steinbock (Oxford: Oxford University Press), 516-535. doi: 10.1093/oxfordhb/9780199562411.003.0023
48. Schelle, K. J., Faulmüller, N., Caviola, L., and Hewstone, M. (2014). Attitudes toward pharmacological cognitive enhancement-a review. Front. Syst. Neurosci. 8:53. doi: 10.3389/fnsys.2014.00053
49. Scheske, C., and Schnall, S. (2012). The ethics of 'Smart Drugs': moral judgments about healthy people's use of cognitive-enhancing drugs. Basic Appl. Soc. Psychol. 34, 508-515. doi: 10.1080/01973533.2012.711692
50. Smith, M. E., and Farah, M. J. (2011). Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychol. Bull. 137, 717-741. doi: 10.1037/a0023825
51. Spranca, M., Minsk, E., and Baron, J. (1991). Omission and commission in judgment and choice. J. Exp. Soc. Psychol. 27, 76-105. doi: 10.1016/0022-1031(91)90011-t
52. Stanovich, K. E. (2004). The Robot's Rebellion. Finding Meaning in the Age of Darwin. Chicago: Chicago University Press.
53. Tversky, A., and Kahneman, D. (1974). Judgment under uncertainty-heuristics and biases. Science 185, 1124-1131. doi: 10.1126/science.185.4157.1124
54. Urban, K. R., and Gao, W.-J. (2014). Performance enhancement at the cost of potential brain plasticity: neural ramifications of nootropic drugs in the healthy developing brain. Front. Syst. Neurosci. 8:38. doi: 10.3389/fnsys.2014.00038
55. Weil, M. M., and Rosen, L. D. (1995). The psychological impact of technology from a global perspective: a study of technological sophistication and technophobia in university students from twenty-three countries. Comput. Hum. Behav. 11, 95-133. doi: 10.1016/0747-5632(94)00026-e
56. Weinberg, B. A., and Bealer, B. K. (2001). The World of Caffeine: The Science and Culture of the World's Most Popular Drug. New York, NY: Routledge.
57. Weinstein, N. D., and Klein, W. M. (1996). Unrealistic optimism: present and future. J. Soc. Clin. Psychol. 15, 1-8. doi: 10.1521/jscp.1996.15.1.1